Linfoma nasal de células T asesinas naturales
PDF (Espanhol)

Palavras-chave

linfoma nasal
granuloma letal de la línea media
radioterapia
virus de Epstein-Barr

Como Citar

Linfoma nasal de células T asesinas naturales. (2010). Universitas Medica, 52(1), 106-111. https://doi.org/10.11144/Javeriana.umed52-1.lnct
Almetrics
 
Dimensions
 

Google Scholar
 
Search GoogleScholar

Resumo

El linfoma nasal de células T asesinas naturales, también conocido como granuloma letal de la línea media, es una entidad poco frecuente. Se trata de un linfoma extraganglionar de comportamiento agresivo que, usualmente, se origina en la cavidad nasal, prevalente en países orientales y en hombres en la tercera década de la vida. Su asociación con infección por el virus de Epstein-Barr actualmente está bien documentada. Su tratamiento es aún controvertido; la tendencia actual está a favor de la radioterapia.

A continuación se presenta un caso de linfoma nasal de células T asesinas naturales y la revisión de la literatura, con el fin de proveer un mayor entendimiento de la enfermedad.

PDF (Espanhol)

Borges A, Fink J, Villablanca P, et al. Midline destructive lesions of the

sinonasal tract: Simplified terminology based on histopathologic criteria. AJNR Am J Neuroradiol. 2000;21:331-6.

Savage KJ, Chhanabhai M, Gascoyne RD, et al. Characterization of peripheral T-cell lymphomas in a single North American institution by the WHO classification. Ann Oncol. 2004; 15:1467-75.

Mishima K, Horiuchi K, Kojya S, et al. Epstein-Barr virus in patients with polymorphic reticulosis (lethal midline granuloma) from China and Japan. Cancer. 1994;73:3041-6.

Aozasa K, Yang WI, Lee YB, et al. Lethal midline granuloma in Seoul

(Korea) and Shanghai (China). Int J Cancer. 1992;52:673-4.

Smalley SR, Cupps RE, Anderson JA, et al. Polymorphic reticulosis limited to the upper aerodigestive tract: Natural history and radiotherapeutic considerations. Int J Radiat Oncol Biol Phys. 1988;15:599-605.

Lipford EH Jr, Margolick JB, Longo DL, et al. Angiocentric immunoproliferative lesions: A clinicopathologic spectrum of post-thymic T-cell proliferations. Blood. 1988;72:1674-81.

Gaal K, Sun NC, Hernández AM, Arber DA. Sinonasal NK/T-cell lymphomas in the United States. Am J Surg Pathol. 2000;24:1511-7.

Daihachiro S, Kazuyoshi U, Yuichi K, Yoshito E. Clinicopathological features of Epstein–Barr virus-associated nasal T:NK cell lymphomas in southern Japan. Auris Nasus Larynx. 2001; 28:61-70.

Sakata K, Hareyama M, Ohuchi A, et al. Treatment of lethal midline granuloma type nasal T-cell lymphoma. Acta Oncol. 1997;36:307-11.

Wei Y, Jeffery C. Stewart, Kratochvil J, Zieper M. Angiocentric T-cell

lymphoma presenting as midface destructive lesion: Case report and

literature review. Oral Surg Oral Med Oral Pathol Oral Radiol Endod.

;94:353-60.

This journal is registered under a Creative Commons Attribution 4.0 International Public License. Thus, this work may be reproduced, distributed, and publicly shared in digital format, as long as the names of the authors and Pontificia Universidad Javeriana are acknowledged. Others are allowed to quote, adapt, transform, auto-archive, republish, and create based on this material, for any purpose (even commercial ones), provided the authorship is duly acknowledged, a link to the original work is provided, and it is specified if changes have been made. Pontificia Universidad Javeriana does not hold the rights of published works and the authors are solely responsible for the contents of their works; they keep the moral, intellectual, privacy, and publicity rights.

Approving the intervention of the work (review, copy-editing, translation, layout) and the following outreach, are granted through an use license and not through an assignment of rights. This means the journal and Pontificia Universidad Javeriana cannot be held responsible for any ethical malpractice by the authors. As a consequence of the protection granted by the use license, the journal is not required to publish recantations or modify information already published, unless the errata stems from the editorial management process. Publishing contents in this journal does not generate royalties for contributors.